Table 3: Logistic regression for factors associated with microalbuminuria among newly diagnosed diabetic patients at Mulago hospital.

Factor Microalbuminuria Crude OR(CI). P-value Adjusted OR P-value
Absent
No (%)
Present
No (%)
Sex Male 44 (48.9) 46 (51.1) 1.00 1.00
Female 48 (56.5) 37 (43.5) 0.74 (0.41-1.34) 0.316 1.21 (0.26-5.70) 0.802
Age < 40 years 25 (50.0) 25 (50.20) 1.00 1.00
40 and above 67 (53.6) 58 (46.4) 0.87 (0.45-1.67) 0.667 1.11 (0.24-5.16) 0.891
Pregnancy No 46 (58.2) 33 (41.8) 1.00 1.00
Yes 1 (16.7) 5 (83.3) 6.84 (0.77-60.98) 0.085 7.74 (1.01-76.47) 0.050
Physical activity at work Sedentary 6 (35.3) 11 (64.7) 1.00 1.00
Mild 25 (52.1) 23 (47.9) 0.47 (0.16-1.42) 0.183 0.08 (0.01-0.95) 0.046
Moderate 38 (53.5) 33 (46.5) 0.37 (0.11-1.22) 0.104 0.07 (0.01-0.77) 0.030
0.030 22 (59.5) 15 (40.5) 0.55 (0.03-1.37) 0.687 0.19 (0.13-2.73) 0.223
Physical activity at leisure Sedentary 63 (51.2) 60 (48.8) 1.00
Moderate 29 (55.8) 23 (44.2) 0.83 (0.43-1.59) 0.582
HbA1C Normal 11 (78.6) 3 (21.4) 1.00 1.00
Abnormal 79 (50.0) 79 (50.0) 3.67 (0.99-13.65) 0.053 2.28 (0.32-16.16) 0.408
Hypertension Normotensive 31 (46.3) 36 (53.7) 1.00 1.00
Hypertensive 61 (56.5) 47 (43.5) 0.66 (0.36-1.22) 0.189 2.38 (0.66-8.57) 0.183
Drugs ACEI/ARBs 5 (55.6) 4 (44.4) 0.88 (0.23-3.40) 0.854
CCBs 9 (75.0) 3 (25.0) 0.35 (0.90-1.32) 0.121 0.38 (0.06-2.27) 0.289
Beta blockers 2 (50.0) 2 (50.0) 1.11 (0.15-8.07) 0.917
DM type Type 1 16 (45.7) 19 (54.3) 1.00 1.00
Type 2 76 (54.3) 64 (45.7) 0.71 (0.34-1.49) 0.365 0.52 (0.08-3.56) 0.507
BMI Normal weight 45 (43.7) 58 (56.3) 1.00 1.00
Over wt & Obesity 47 (65.3) 25 (34.7) 0.41 (0.22-0.77) 0.005 0.37 (0.12-1.13) 0.082
Ejection fraction > 50% 74 (53.2) 65 (46.8) 1.00
< 50% 18 (50.0) 18 (50.0) 1.14 (0.55-2.37) 0.729
LVH Absent 36 (46.7) 41 (53.3) 1.00
Present 56 (57.1) 42 (42.9) 0.66 (0.36-1.20) 0.173

OR: Odds Ratio; N: Number; %: Percentage; CI: Confidence Interval; BMI: Body Mass Index; DM: Diabetes Mellitus; LVH: Left Ventricular Hypertrophy; ACEI: Angiotensin Converting Enzyme Inhibitor; ARB: Angiotensin Receptor Blocker; CCB: Calcium Channel Blocker.